AMD Before and After Anti-VEGF Drugs

A new study funded by the National Eye Institute finds that anti-VEGF treatments have greatly improved the prognosis for patients with AMD.

This study followed up with participants from the Comparison of AMD Treatments Trials (CATT) five years after the initial trial. 50 percent of patients who received anti-VEGF treatments had 20/40 vision or better, 20 percent had 20/200 vision or worse, while the rest were in between. This is a large improvement over photodynamic therapy, the best available treatment from ten years ago, where less than 15 percent of patients retain 20/40 vision.

The trial also compared outcomes for patients receiving different anti-VEGF treatments, ranibizumab (Lucentis) and bevacizumab (Avastin). Treatment with ranibizumab is approximately $1,575 per month in Canada, while bevacizumab costs around $7 per month.

“Some experts had speculated that two years of treatment with ranibizumab might have long-term benefits superior to bevacizumab. However, at five years, there were no differences in visual acuity between the two drugs,” said Daniel F. Martin, M.D., chair of the Cleveland Clinic Cole Eye Institute and CATT study chair.

Full paper available here.

Featured Posts

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Learn More

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read more

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read more

And the 2022 SILMO d’Or Goes To…!

Here are the winners, by category:

Read more

AYA’s Huron: A Modern Twist to a Classic Style

The Huron is a classic styling with a modern twist. This lightweight stainless-steel model has subtle detailing to make for a very professional yet creative looking frame.

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Learn More

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read More

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read More

And the 2022 SILMO d’Or Goes To…!

Here are the winners, by category:

Read More

AYA’s Huron: A Modern Twist to a Classic Style

The Huron is a classic styling with a modern twist. This lightweight stainless-steel model has subtle detailing to make for a very professional yet creative looking frame.

Read More

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Learn More

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read more

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read more

And the 2022 SILMO d’Or Goes To…!

Here are the winners, by category:

Read more

AYA’s Huron: A Modern Twist to a Classic Style

The Huron is a classic styling with a modern twist. This lightweight stainless-steel model has subtle detailing to make for a very professional yet creative looking frame.

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Learn More

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read more

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read more

And the 2022 SILMO d’Or Goes To…!

Here are the winners, by category:

Read more

AYA’s Huron: A Modern Twist to a Classic Style

The Huron is a classic styling with a modern twist. This lightweight stainless-steel model has subtle detailing to make for a very professional yet creative looking frame.

Read more